nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2D6—Fingolimod—multiple sclerosis	0.0884	0.231	CbGbCtD
Tramadol—CYP3A4—Fingolimod—multiple sclerosis	0.0562	0.147	CbGbCtD
Tramadol—CYP2B6—Dexamethasone—multiple sclerosis	0.0446	0.116	CbGbCtD
Tramadol—CYP3A4—Methylprednisolone—multiple sclerosis	0.0362	0.0945	CbGbCtD
Tramadol—CYP3A4—Triamcinolone—multiple sclerosis	0.0275	0.0716	CbGbCtD
Tramadol—CYP3A4—Mitoxantrone—multiple sclerosis	0.0264	0.069	CbGbCtD
Tramadol—CYP3A4—Betamethasone—multiple sclerosis	0.0236	0.0615	CbGbCtD
Tramadol—CYP3A4—Prednisolone—multiple sclerosis	0.0233	0.0606	CbGbCtD
Tramadol—CYP3A4—Prednisone—multiple sclerosis	0.022	0.0573	CbGbCtD
Tramadol—CYP2D6—Dexamethasone—multiple sclerosis	0.0216	0.0562	CbGbCtD
Tramadol—CYP3A4—Dexamethasone—multiple sclerosis	0.0137	0.0357	CbGbCtD
Tramadol—OPRM1—nerve—multiple sclerosis	0.0053	0.0829	CbGeAlD
Tramadol—SLC6A2—nerve—multiple sclerosis	0.00388	0.0607	CbGeAlD
Tramadol—GRIN3A—nervous system—multiple sclerosis	0.00248	0.0388	CbGeAlD
Tramadol—GRIN3A—central nervous system—multiple sclerosis	0.00239	0.0373	CbGeAlD
Tramadol—OPRM1—brainstem—multiple sclerosis	0.00227	0.0356	CbGeAlD
Tramadol—HTR2C—brainstem—multiple sclerosis	0.002	0.0312	CbGeAlD
Tramadol—GRIN3A—brain—multiple sclerosis	0.0019	0.0296	CbGeAlD
Tramadol—SLC6A4—brainstem—multiple sclerosis	0.00189	0.0296	CbGeAlD
Tramadol—OPRD1—nervous system—multiple sclerosis	0.00175	0.0273	CbGeAlD
Tramadol—OPRD1—central nervous system—multiple sclerosis	0.00168	0.0263	CbGeAlD
Tramadol—OPRK1—nervous system—multiple sclerosis	0.00168	0.0262	CbGeAlD
Tramadol—SLC6A2—brainstem—multiple sclerosis	0.00167	0.026	CbGeAlD
Tramadol—OPRK1—central nervous system—multiple sclerosis	0.00161	0.0252	CbGeAlD
Tramadol—OPRK1—cerebellum—multiple sclerosis	0.00158	0.0246	CbGeAlD
Tramadol—OPRM1—midbrain—multiple sclerosis	0.00145	0.0227	CbGeAlD
Tramadol—OPRM1—spinal cord—multiple sclerosis	0.00141	0.0221	CbGeAlD
Tramadol—HTR2C—medulla oblongata—multiple sclerosis	0.00139	0.0218	CbGeAlD
Tramadol—OPRD1—brain—multiple sclerosis	0.00134	0.0209	CbGeAlD
Tramadol—OPRK1—brain—multiple sclerosis	0.00128	0.02	CbGeAlD
Tramadol—HTR2C—midbrain—multiple sclerosis	0.00127	0.0199	CbGeAlD
Tramadol—HTR2C—spinal cord—multiple sclerosis	0.00124	0.0194	CbGeAlD
Tramadol—SLC6A4—midbrain—multiple sclerosis	0.00121	0.0189	CbGeAlD
Tramadol—OPRM1—nervous system—multiple sclerosis	0.00119	0.0186	CbGeAlD
Tramadol—SLC6A4—spinal cord—multiple sclerosis	0.00118	0.0184	CbGeAlD
Tramadol—SLC6A2—medulla oblongata—multiple sclerosis	0.00116	0.0182	CbGeAlD
Tramadol—OPRM1—central nervous system—multiple sclerosis	0.00115	0.0179	CbGeAlD
Tramadol—HTR2C—nervous system—multiple sclerosis	0.00105	0.0163	CbGeAlD
Tramadol—HTR2C—central nervous system—multiple sclerosis	0.00101	0.0157	CbGeAlD
Tramadol—SLC6A4—nervous system—multiple sclerosis	0.000991	0.0155	CbGeAlD
Tramadol—SLC6A4—central nervous system—multiple sclerosis	0.000954	0.0149	CbGeAlD
Tramadol—CYP2D6—brainstem—multiple sclerosis	0.000912	0.0143	CbGeAlD
Tramadol—OPRM1—brain—multiple sclerosis	0.000911	0.0142	CbGeAlD
Tramadol—CHRM3—nervous system—multiple sclerosis	0.000883	0.0138	CbGeAlD
Tramadol—SLC6A2—nervous system—multiple sclerosis	0.000872	0.0136	CbGeAlD
Tramadol—CHRM3—central nervous system—multiple sclerosis	0.000851	0.0133	CbGeAlD
Tramadol—SLC6A2—central nervous system—multiple sclerosis	0.00084	0.0131	CbGeAlD
Tramadol—HTR2C—brain—multiple sclerosis	0.000799	0.0125	CbGeAlD
Tramadol—SLC6A4—brain—multiple sclerosis	0.000757	0.0118	CbGeAlD
Tramadol—CHRM3—brain—multiple sclerosis	0.000675	0.0106	CbGeAlD
Tramadol—SLC6A2—brain—multiple sclerosis	0.000667	0.0104	CbGeAlD
Tramadol—CYP2B6—nervous system—multiple sclerosis	0.000643	0.0101	CbGeAlD
Tramadol—CYP2B6—central nervous system—multiple sclerosis	0.000619	0.00968	CbGeAlD
Tramadol—CYP2B6—brain—multiple sclerosis	0.000491	0.00768	CbGeAlD
Tramadol—CYP3A4—nervous system—multiple sclerosis	0.000485	0.00759	CbGeAlD
Tramadol—CYP2D6—nervous system—multiple sclerosis	0.000478	0.00747	CbGeAlD
Tramadol—CYP3A4—central nervous system—multiple sclerosis	0.000467	0.00731	CbGeAlD
Tramadol—CYP2D6—central nervous system—multiple sclerosis	0.00046	0.00719	CbGeAlD
Tramadol—CYP2D6—cerebellum—multiple sclerosis	0.00045	0.00703	CbGeAlD
Tramadol—CYP2D6—brain—multiple sclerosis	0.000365	0.00571	CbGeAlD
Tramadol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000181	0.000424	CcSEcCtD
Tramadol—Paraesthesia—Prednisolone—multiple sclerosis	0.000181	0.000423	CcSEcCtD
Tramadol—Tachycardia—Triamcinolone—multiple sclerosis	0.000181	0.000423	CcSEcCtD
Tramadol—Mental disorder—Prednisone—multiple sclerosis	0.000181	0.000423	CcSEcCtD
Tramadol—Nausea—Azathioprine—multiple sclerosis	0.000181	0.000422	CcSEcCtD
Tramadol—Tachycardia—Methylprednisolone—multiple sclerosis	0.000181	0.000422	CcSEcCtD
Tramadol—Skin disorder—Methylprednisolone—multiple sclerosis	0.00018	0.00042	CcSEcCtD
Tramadol—Erythema—Prednisone—multiple sclerosis	0.00018	0.00042	CcSEcCtD
Tramadol—Malnutrition—Prednisone—multiple sclerosis	0.00018	0.00042	CcSEcCtD
Tramadol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000179	0.000419	CcSEcCtD
Tramadol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000179	0.000418	CcSEcCtD
Tramadol—Convulsion—Betamethasone—multiple sclerosis	0.000179	0.000418	CcSEcCtD
Tramadol—Convulsion—Dexamethasone—multiple sclerosis	0.000179	0.000418	CcSEcCtD
Tramadol—Hypertension—Dexamethasone—multiple sclerosis	0.000178	0.000416	CcSEcCtD
Tramadol—Hypertension—Betamethasone—multiple sclerosis	0.000178	0.000416	CcSEcCtD
Tramadol—Asthenia—Mitoxantrone—multiple sclerosis	0.000177	0.000412	CcSEcCtD
Tramadol—Myalgia—Dexamethasone—multiple sclerosis	0.000176	0.000411	CcSEcCtD
Tramadol—Myalgia—Betamethasone—multiple sclerosis	0.000176	0.000411	CcSEcCtD
Tramadol—Anxiety—Dexamethasone—multiple sclerosis	0.000175	0.000409	CcSEcCtD
Tramadol—Anxiety—Betamethasone—multiple sclerosis	0.000175	0.000409	CcSEcCtD
Tramadol—Discomfort—Betamethasone—multiple sclerosis	0.000174	0.000406	CcSEcCtD
Tramadol—Discomfort—Dexamethasone—multiple sclerosis	0.000174	0.000406	CcSEcCtD
Tramadol—Haemoglobin—Methotrexate—multiple sclerosis	0.000173	0.000405	CcSEcCtD
Tramadol—Hypotension—Methylprednisolone—multiple sclerosis	0.000173	0.000404	CcSEcCtD
Tramadol—Pain—Prednisolone—multiple sclerosis	0.000173	0.000403	CcSEcCtD
Tramadol—Haemorrhage—Methotrexate—multiple sclerosis	0.000173	0.000403	CcSEcCtD
Tramadol—Hepatitis—Methotrexate—multiple sclerosis	0.000173	0.000403	CcSEcCtD
Tramadol—Pharyngitis—Methotrexate—multiple sclerosis	0.000171	0.0004	CcSEcCtD
Tramadol—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00017	0.000398	CcSEcCtD
Tramadol—Vision blurred—Prednisone—multiple sclerosis	0.000169	0.000396	CcSEcCtD
Tramadol—Urethral disorder—Methotrexate—multiple sclerosis	0.000169	0.000395	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000169	0.000395	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000169	0.000394	CcSEcCtD
Tramadol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000168	0.000394	CcSEcCtD
Tramadol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000168	0.000394	CcSEcCtD
Tramadol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000168	0.000393	CcSEcCtD
Tramadol—Insomnia—Triamcinolone—multiple sclerosis	0.000168	0.000392	CcSEcCtD
Tramadol—Insomnia—Methylprednisolone—multiple sclerosis	0.000168	0.000391	CcSEcCtD
Tramadol—Infection—Betamethasone—multiple sclerosis	0.000167	0.000391	CcSEcCtD
Tramadol—Infection—Dexamethasone—multiple sclerosis	0.000167	0.000391	CcSEcCtD
Tramadol—Ill-defined disorder—Prednisone—multiple sclerosis	0.000167	0.00039	CcSEcCtD
Tramadol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000167	0.000389	CcSEcCtD
Tramadol—Feeling abnormal—Prednisolone—multiple sclerosis	0.000166	0.000389	CcSEcCtD
Tramadol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000166	0.000389	CcSEcCtD
Tramadol—Visual impairment—Methotrexate—multiple sclerosis	0.000166	0.000389	CcSEcCtD
Tramadol—Anaemia—Prednisone—multiple sclerosis	0.000166	0.000388	CcSEcCtD
Tramadol—Shock—Dexamethasone—multiple sclerosis	0.000166	0.000387	CcSEcCtD
Tramadol—Shock—Betamethasone—multiple sclerosis	0.000166	0.000387	CcSEcCtD
Tramadol—Dyspnoea—Triamcinolone—multiple sclerosis	0.000165	0.000387	CcSEcCtD
Tramadol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000165	0.000386	CcSEcCtD
Tramadol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000165	0.000386	CcSEcCtD
Tramadol—Agitation—Prednisone—multiple sclerosis	0.000165	0.000386	CcSEcCtD
Tramadol—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000165	0.000385	CcSEcCtD
Tramadol—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000165	0.000385	CcSEcCtD
Tramadol—Tachycardia—Dexamethasone—multiple sclerosis	0.000164	0.000384	CcSEcCtD
Tramadol—Tachycardia—Betamethasone—multiple sclerosis	0.000164	0.000384	CcSEcCtD
Tramadol—Angioedema—Prednisone—multiple sclerosis	0.000164	0.000384	CcSEcCtD
Tramadol—Dyspepsia—Triamcinolone—multiple sclerosis	0.000163	0.000382	CcSEcCtD
Tramadol—Erythema multiforme—Methotrexate—multiple sclerosis	0.000163	0.000381	CcSEcCtD
Tramadol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000163	0.000381	CcSEcCtD
Tramadol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000163	0.00038	CcSEcCtD
Tramadol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000163	0.00038	CcSEcCtD
Tramadol—Malaise—Prednisone—multiple sclerosis	0.000162	0.000379	CcSEcCtD
Tramadol—Vertigo—Prednisone—multiple sclerosis	0.000161	0.000377	CcSEcCtD
Tramadol—Eye disorder—Methotrexate—multiple sclerosis	0.000161	0.000377	CcSEcCtD
Tramadol—Syncope—Prednisone—multiple sclerosis	0.000161	0.000377	CcSEcCtD
Tramadol—Tinnitus—Methotrexate—multiple sclerosis	0.000161	0.000376	CcSEcCtD
Tramadol—Anorexia—Dexamethasone—multiple sclerosis	0.000161	0.000375	CcSEcCtD
Tramadol—Anorexia—Betamethasone—multiple sclerosis	0.000161	0.000375	CcSEcCtD
Tramadol—Urticaria—Prednisolone—multiple sclerosis	0.00016	0.000375	CcSEcCtD
Tramadol—Cardiac disorder—Methotrexate—multiple sclerosis	0.00016	0.000374	CcSEcCtD
Tramadol—Fatigue—Triamcinolone—multiple sclerosis	0.00016	0.000374	CcSEcCtD
Tramadol—Fatigue—Methylprednisolone—multiple sclerosis	0.00016	0.000373	CcSEcCtD
Tramadol—Pain—Triamcinolone—multiple sclerosis	0.000159	0.000371	CcSEcCtD
Tramadol—Loss of consciousness—Prednisone—multiple sclerosis	0.000158	0.000369	CcSEcCtD
Tramadol—Hypotension—Betamethasone—multiple sclerosis	0.000157	0.000368	CcSEcCtD
Tramadol—Hypotension—Dexamethasone—multiple sclerosis	0.000157	0.000368	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—multiple sclerosis	0.000157	0.000366	CcSEcCtD
Tramadol—Vomiting—Mitoxantrone—multiple sclerosis	0.000156	0.000366	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—multiple sclerosis	0.000156	0.000364	CcSEcCtD
Tramadol—Convulsion—Prednisone—multiple sclerosis	0.000156	0.000364	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000156	0.000363	CcSEcCtD
Tramadol—Hypertension—Prednisone—multiple sclerosis	0.000155	0.000363	CcSEcCtD
Tramadol—Rash—Mitoxantrone—multiple sclerosis	0.000155	0.000362	CcSEcCtD
Tramadol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000155	0.000362	CcSEcCtD
Tramadol—Chills—Methotrexate—multiple sclerosis	0.000155	0.000362	CcSEcCtD
Tramadol—Headache—Mitoxantrone—multiple sclerosis	0.000154	0.00036	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000153	0.000359	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000153	0.000359	CcSEcCtD
Tramadol—Arthralgia—Prednisone—multiple sclerosis	0.000153	0.000358	CcSEcCtD
Tramadol—Myalgia—Prednisone—multiple sclerosis	0.000153	0.000358	CcSEcCtD
Tramadol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000153	0.000357	CcSEcCtD
Tramadol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000153	0.000357	CcSEcCtD
Tramadol—Anxiety—Prednisone—multiple sclerosis	0.000152	0.000356	CcSEcCtD
Tramadol—Insomnia—Betamethasone—multiple sclerosis	0.000152	0.000356	CcSEcCtD
Tramadol—Insomnia—Dexamethasone—multiple sclerosis	0.000152	0.000356	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000152	0.000355	CcSEcCtD
Tramadol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000151	0.000354	CcSEcCtD
Tramadol—Paraesthesia—Betamethasone—multiple sclerosis	0.000151	0.000353	CcSEcCtD
Tramadol—Paraesthesia—Dexamethasone—multiple sclerosis	0.000151	0.000353	CcSEcCtD
Tramadol—Discomfort—Prednisone—multiple sclerosis	0.000151	0.000353	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—multiple sclerosis	0.000151	0.000353	CcSEcCtD
Tramadol—Erythema—Methotrexate—multiple sclerosis	0.00015	0.000351	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—multiple sclerosis	0.00015	0.000351	CcSEcCtD
Tramadol—Hypersensitivity—Prednisolone—multiple sclerosis	0.000149	0.000347	CcSEcCtD
Tramadol—Dyspepsia—Betamethasone—multiple sclerosis	0.000148	0.000346	CcSEcCtD
Tramadol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000148	0.000346	CcSEcCtD
Tramadol—Urticaria—Triamcinolone—multiple sclerosis	0.000147	0.000345	CcSEcCtD
Tramadol—Urticaria—Methylprednisolone—multiple sclerosis	0.000147	0.000344	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—multiple sclerosis	0.000147	0.000344	CcSEcCtD
Tramadol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000147	0.000343	CcSEcCtD
Tramadol—Anaphylactic shock—Prednisone—multiple sclerosis	0.000147	0.000343	CcSEcCtD
Tramadol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000146	0.000342	CcSEcCtD
Tramadol—Decreased appetite—Dexamethasone—multiple sclerosis	0.000146	0.000342	CcSEcCtD
Tramadol—Decreased appetite—Betamethasone—multiple sclerosis	0.000146	0.000342	CcSEcCtD
Tramadol—Nausea—Mitoxantrone—multiple sclerosis	0.000146	0.000341	CcSEcCtD
Tramadol—Infection—Prednisone—multiple sclerosis	0.000146	0.00034	CcSEcCtD
Tramadol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000145	0.00034	CcSEcCtD
Tramadol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000145	0.00034	CcSEcCtD
Tramadol—Back pain—Methotrexate—multiple sclerosis	0.000145	0.000339	CcSEcCtD
Tramadol—Fatigue—Dexamethasone—multiple sclerosis	0.000145	0.000339	CcSEcCtD
Tramadol—Fatigue—Betamethasone—multiple sclerosis	0.000145	0.000339	CcSEcCtD
Tramadol—Shock—Prednisone—multiple sclerosis	0.000144	0.000337	CcSEcCtD
Tramadol—Pain—Dexamethasone—multiple sclerosis	0.000144	0.000337	CcSEcCtD
Tramadol—Pain—Betamethasone—multiple sclerosis	0.000144	0.000337	CcSEcCtD
Tramadol—Nervous system disorder—Prednisone—multiple sclerosis	0.000144	0.000336	CcSEcCtD
Tramadol—Tachycardia—Prednisone—multiple sclerosis	0.000143	0.000334	CcSEcCtD
Tramadol—Skin disorder—Prednisone—multiple sclerosis	0.000142	0.000333	CcSEcCtD
Tramadol—Hyperhidrosis—Prednisone—multiple sclerosis	0.000142	0.000331	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—multiple sclerosis	0.000142	0.000331	CcSEcCtD
Tramadol—Anorexia—Prednisone—multiple sclerosis	0.00014	0.000327	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000139	0.000326	CcSEcCtD
Tramadol—Anaemia—Methotrexate—multiple sclerosis	0.000139	0.000324	CcSEcCtD
Tramadol—Feeling abnormal—Betamethasone—multiple sclerosis	0.000139	0.000324	CcSEcCtD
Tramadol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000139	0.000324	CcSEcCtD
Tramadol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000138	0.000322	CcSEcCtD
Tramadol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000138	0.000322	CcSEcCtD
Tramadol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000137	0.00032	CcSEcCtD
Tramadol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000136	0.000319	CcSEcCtD
Tramadol—Malaise—Methotrexate—multiple sclerosis	0.000135	0.000316	CcSEcCtD
Tramadol—Vertigo—Methotrexate—multiple sclerosis	0.000135	0.000315	CcSEcCtD
Tramadol—Urticaria—Betamethasone—multiple sclerosis	0.000134	0.000313	CcSEcCtD
Tramadol—Urticaria—Dexamethasone—multiple sclerosis	0.000134	0.000313	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000134	0.000312	CcSEcCtD
Tramadol—Dizziness—Prednisolone—multiple sclerosis	0.000133	0.000312	CcSEcCtD
Tramadol—Asthenia—Triamcinolone—multiple sclerosis	0.000133	0.000311	CcSEcCtD
Tramadol—Abdominal pain—Dexamethasone—multiple sclerosis	0.000133	0.000311	CcSEcCtD
Tramadol—Body temperature increased—Betamethasone—multiple sclerosis	0.000133	0.000311	CcSEcCtD
Tramadol—Body temperature increased—Dexamethasone—multiple sclerosis	0.000133	0.000311	CcSEcCtD
Tramadol—Abdominal pain—Betamethasone—multiple sclerosis	0.000133	0.000311	CcSEcCtD
Tramadol—Asthenia—Methylprednisolone—multiple sclerosis	0.000133	0.00031	CcSEcCtD
Tramadol—Insomnia—Prednisone—multiple sclerosis	0.000133	0.00031	CcSEcCtD
Tramadol—Paraesthesia—Prednisone—multiple sclerosis	0.000132	0.000308	CcSEcCtD
Tramadol—Pruritus—Triamcinolone—multiple sclerosis	0.000131	0.000307	CcSEcCtD
Tramadol—Cough—Methotrexate—multiple sclerosis	0.000131	0.000306	CcSEcCtD
Tramadol—Pruritus—Methylprednisolone—multiple sclerosis	0.000131	0.000306	CcSEcCtD
Tramadol—Convulsion—Methotrexate—multiple sclerosis	0.00013	0.000304	CcSEcCtD
Tramadol—Dyspepsia—Prednisone—multiple sclerosis	0.000129	0.000302	CcSEcCtD
Tramadol—Myalgia—Methotrexate—multiple sclerosis	0.000128	0.000299	CcSEcCtD
Tramadol—Chest pain—Methotrexate—multiple sclerosis	0.000128	0.000299	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—multiple sclerosis	0.000128	0.000299	CcSEcCtD
Tramadol—Decreased appetite—Prednisone—multiple sclerosis	0.000128	0.000298	CcSEcCtD
Tramadol—Rash—Prednisolone—multiple sclerosis	0.000127	0.000297	CcSEcCtD
Tramadol—Dermatitis—Prednisolone—multiple sclerosis	0.000127	0.000297	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000127	0.000297	CcSEcCtD
Tramadol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000127	0.000296	CcSEcCtD
Tramadol—Fatigue—Prednisone—multiple sclerosis	0.000126	0.000295	CcSEcCtD
Tramadol—Headache—Prednisolone—multiple sclerosis	0.000126	0.000295	CcSEcCtD
Tramadol—Discomfort—Methotrexate—multiple sclerosis	0.000126	0.000295	CcSEcCtD
Tramadol—Constipation—Prednisone—multiple sclerosis	0.000125	0.000293	CcSEcCtD
Tramadol—Confusional state—Methotrexate—multiple sclerosis	0.000124	0.000289	CcSEcCtD
Tramadol—Dizziness—Triamcinolone—multiple sclerosis	0.000123	0.000287	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000123	0.000286	CcSEcCtD
Tramadol—Dizziness—Methylprednisolone—multiple sclerosis	0.000122	0.000286	CcSEcCtD
Tramadol—Infection—Methotrexate—multiple sclerosis	0.000122	0.000285	CcSEcCtD
Tramadol—Feeling abnormal—Prednisone—multiple sclerosis	0.000121	0.000282	CcSEcCtD
Tramadol—Asthenia—Dexamethasone—multiple sclerosis	0.000121	0.000282	CcSEcCtD
Tramadol—Asthenia—Betamethasone—multiple sclerosis	0.000121	0.000282	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—multiple sclerosis	0.00012	0.000281	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00012	0.00028	CcSEcCtD
Tramadol—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00012	0.00028	CcSEcCtD
Tramadol—Nausea—Prednisolone—multiple sclerosis	0.00012	0.00028	CcSEcCtD
Tramadol—Pruritus—Betamethasone—multiple sclerosis	0.000119	0.000278	CcSEcCtD
Tramadol—Pruritus—Dexamethasone—multiple sclerosis	0.000119	0.000278	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—multiple sclerosis	0.000119	0.000278	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000119	0.000277	CcSEcCtD
Tramadol—Vomiting—Triamcinolone—multiple sclerosis	0.000118	0.000276	CcSEcCtD
Tramadol—Vomiting—Methylprednisolone—multiple sclerosis	0.000118	0.000275	CcSEcCtD
Tramadol—Rash—Triamcinolone—multiple sclerosis	0.000117	0.000273	CcSEcCtD
Tramadol—Dermatitis—Triamcinolone—multiple sclerosis	0.000117	0.000273	CcSEcCtD
Tramadol—Anorexia—Methotrexate—multiple sclerosis	0.000117	0.000273	CcSEcCtD
Tramadol—Rash—Methylprednisolone—multiple sclerosis	0.000117	0.000273	CcSEcCtD
Tramadol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000117	0.000273	CcSEcCtD
Tramadol—Urticaria—Prednisone—multiple sclerosis	0.000117	0.000272	CcSEcCtD
Tramadol—Headache—Triamcinolone—multiple sclerosis	0.000116	0.000272	CcSEcCtD
Tramadol—Headache—Methylprednisolone—multiple sclerosis	0.000116	0.000271	CcSEcCtD
Tramadol—Abdominal pain—Prednisone—multiple sclerosis	0.000116	0.000271	CcSEcCtD
Tramadol—Body temperature increased—Prednisone—multiple sclerosis	0.000116	0.000271	CcSEcCtD
Tramadol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000115	0.000269	CcSEcCtD
Tramadol—Diarrhoea—Betamethasone—multiple sclerosis	0.000115	0.000269	CcSEcCtD
Tramadol—Hypotension—Methotrexate—multiple sclerosis	0.000115	0.000268	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000112	0.000261	CcSEcCtD
Tramadol—Dizziness—Betamethasone—multiple sclerosis	0.000111	0.00026	CcSEcCtD
Tramadol—Dizziness—Dexamethasone—multiple sclerosis	0.000111	0.00026	CcSEcCtD
Tramadol—Insomnia—Methotrexate—multiple sclerosis	0.000111	0.000259	CcSEcCtD
Tramadol—Nausea—Triamcinolone—multiple sclerosis	0.00011	0.000258	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—multiple sclerosis	0.00011	0.000257	CcSEcCtD
Tramadol—Nausea—Methylprednisolone—multiple sclerosis	0.00011	0.000257	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—multiple sclerosis	0.000109	0.000255	CcSEcCtD
Tramadol—Somnolence—Methotrexate—multiple sclerosis	0.000109	0.000255	CcSEcCtD
Tramadol—Hypersensitivity—Prednisone—multiple sclerosis	0.000108	0.000252	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—multiple sclerosis	0.000108	0.000252	CcSEcCtD
Tramadol—Vomiting—Betamethasone—multiple sclerosis	0.000107	0.00025	CcSEcCtD
Tramadol—Vomiting—Dexamethasone—multiple sclerosis	0.000107	0.00025	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—multiple sclerosis	0.000107	0.000249	CcSEcCtD
Tramadol—Rash—Dexamethasone—multiple sclerosis	0.000106	0.000248	CcSEcCtD
Tramadol—Rash—Betamethasone—multiple sclerosis	0.000106	0.000248	CcSEcCtD
Tramadol—Dermatitis—Betamethasone—multiple sclerosis	0.000106	0.000248	CcSEcCtD
Tramadol—Dermatitis—Dexamethasone—multiple sclerosis	0.000106	0.000248	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000106	0.000247	CcSEcCtD
Tramadol—Fatigue—Methotrexate—multiple sclerosis	0.000106	0.000247	CcSEcCtD
Tramadol—Headache—Dexamethasone—multiple sclerosis	0.000106	0.000247	CcSEcCtD
Tramadol—Headache—Betamethasone—multiple sclerosis	0.000106	0.000247	CcSEcCtD
Tramadol—Asthenia—Prednisone—multiple sclerosis	0.000105	0.000246	CcSEcCtD
Tramadol—Pain—Methotrexate—multiple sclerosis	0.000105	0.000245	CcSEcCtD
Tramadol—Pruritus—Prednisone—multiple sclerosis	0.000104	0.000242	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—multiple sclerosis	0.000101	0.000236	CcSEcCtD
Tramadol—Diarrhoea—Prednisone—multiple sclerosis	0.0001	0.000234	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.0001	0.000234	CcSEcCtD
Tramadol—Nausea—Dexamethasone—multiple sclerosis	0.0001	0.000234	CcSEcCtD
Tramadol—Nausea—Betamethasone—multiple sclerosis	0.0001	0.000234	CcSEcCtD
Tramadol—Urticaria—Methotrexate—multiple sclerosis	9.74e-05	0.000228	CcSEcCtD
Tramadol—Dizziness—Prednisone—multiple sclerosis	9.7e-05	0.000227	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—multiple sclerosis	9.69e-05	0.000226	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—multiple sclerosis	9.69e-05	0.000226	CcSEcCtD
Tramadol—Vomiting—Prednisone—multiple sclerosis	9.33e-05	0.000218	CcSEcCtD
Tramadol—Rash—Prednisone—multiple sclerosis	9.25e-05	0.000216	CcSEcCtD
Tramadol—Dermatitis—Prednisone—multiple sclerosis	9.24e-05	0.000216	CcSEcCtD
Tramadol—Headache—Prednisone—multiple sclerosis	9.19e-05	0.000215	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—multiple sclerosis	9.03e-05	0.000211	CcSEcCtD
Tramadol—Asthenia—Methotrexate—multiple sclerosis	8.8e-05	0.000205	CcSEcCtD
Tramadol—Nausea—Prednisone—multiple sclerosis	8.71e-05	0.000204	CcSEcCtD
Tramadol—Pruritus—Methotrexate—multiple sclerosis	8.67e-05	0.000203	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—multiple sclerosis	8.39e-05	0.000196	CcSEcCtD
Tramadol—Dizziness—Methotrexate—multiple sclerosis	8.11e-05	0.000189	CcSEcCtD
Tramadol—Vomiting—Methotrexate—multiple sclerosis	7.79e-05	0.000182	CcSEcCtD
Tramadol—Rash—Methotrexate—multiple sclerosis	7.73e-05	0.000181	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—multiple sclerosis	7.72e-05	0.00018	CcSEcCtD
Tramadol—Headache—Methotrexate—multiple sclerosis	7.68e-05	0.000179	CcSEcCtD
Tramadol—Nausea—Methotrexate—multiple sclerosis	7.28e-05	0.00017	CcSEcCtD
Tramadol—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	5.91e-05	0.000474	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CNR1—multiple sclerosis	5.85e-05	0.000469	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	5.83e-05	0.000468	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PTGER4—multiple sclerosis	5.81e-05	0.000466	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GPR65—multiple sclerosis	5.77e-05	0.000463	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCR2—multiple sclerosis	5.76e-05	0.000462	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	5.74e-05	0.000461	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	5.69e-05	0.000456	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	5.67e-05	0.000455	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	5.66e-05	0.000455	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—POMC—multiple sclerosis	5.65e-05	0.000453	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	5.63e-05	0.000452	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCR3—multiple sclerosis	5.61e-05	0.00045	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PGR—multiple sclerosis	5.6e-05	0.000449	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	5.57e-05	0.000447	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	5.55e-05	0.000445	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CCL2—multiple sclerosis	5.53e-05	0.000443	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	5.49e-05	0.000441	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	5.48e-05	0.00044	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	5.46e-05	0.000438	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CD28—multiple sclerosis	5.44e-05	0.000437	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	5.34e-05	0.000429	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CNR1—multiple sclerosis	5.31e-05	0.000426	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	5.28e-05	0.000424	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR1—multiple sclerosis	5.28e-05	0.000423	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL13—multiple sclerosis	5.28e-05	0.000423	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	5.27e-05	0.000423	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL10—multiple sclerosis	5.27e-05	0.000423	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	5.24e-05	0.00042	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	5.18e-05	0.000416	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	5.11e-05	0.00041	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—RRM1—multiple sclerosis	5.11e-05	0.00041	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	5.09e-05	0.000409	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	5.04e-05	0.000404	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	5.04e-05	0.000404	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	5.02e-05	0.000402	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	4.99e-05	0.0004	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	4.97e-05	0.000399	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	4.96e-05	0.000398	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.95e-05	0.000397	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	4.93e-05	0.000396	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PGR—multiple sclerosis	4.91e-05	0.000394	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.88e-05	0.000391	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	4.86e-05	0.00039	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	4.82e-05	0.000386	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	4.79e-05	0.000385	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL10—multiple sclerosis	4.78e-05	0.000384	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CD28—multiple sclerosis	4.77e-05	0.000383	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	4.76e-05	0.000382	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	4.76e-05	0.000382	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	4.69e-05	0.000376	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.69e-05	0.000376	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.69e-05	0.000376	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	4.68e-05	0.000376	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	4.57e-05	0.000367	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	4.56e-05	0.000365	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	4.54e-05	0.000364	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	4.54e-05	0.000364	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	4.53e-05	0.000364	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CCL5—multiple sclerosis	4.53e-05	0.000364	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	4.46e-05	0.000358	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	4.44e-05	0.000356	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	4.4e-05	0.000353	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	4.38e-05	0.000351	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.35e-05	0.000349	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SRM—multiple sclerosis	4.35e-05	0.000349	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	4.32e-05	0.000347	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	4.32e-05	0.000347	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.29e-05	0.000344	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	4.26e-05	0.000342	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	4.21e-05	0.000338	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PGR—multiple sclerosis	4.15e-05	0.000333	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	4.12e-05	0.00033	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCL5—multiple sclerosis	4.12e-05	0.00033	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	4.08e-05	0.000328	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	4.07e-05	0.000327	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	4.05e-05	0.000325	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CD28—multiple sclerosis	4.03e-05	0.000324	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.03e-05	0.000323	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	4.03e-05	0.000323	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	3.99e-05	0.00032	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	3.96e-05	0.000318	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	3.91e-05	0.000314	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	3.9e-05	0.000313	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	3.89e-05	0.000312	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CD86—multiple sclerosis	3.88e-05	0.000311	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	3.82e-05	0.000307	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	3.76e-05	0.000302	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.75e-05	0.000301	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	3.72e-05	0.000298	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	3.71e-05	0.000298	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	3.71e-05	0.000298	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	3.66e-05	0.000293	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	3.65e-05	0.000293	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	3.62e-05	0.00029	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PGR—multiple sclerosis	3.56e-05	0.000286	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.55e-05	0.000285	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	3.55e-05	0.000285	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	3.54e-05	0.000284	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	3.54e-05	0.000284	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	3.52e-05	0.000282	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	3.5e-05	0.00028	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	3.47e-05	0.000278	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CD28—multiple sclerosis	3.46e-05	0.000278	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	3.44e-05	0.000276	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—BCHE—multiple sclerosis	3.41e-05	0.000274	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CD86—multiple sclerosis	3.4e-05	0.000273	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	3.4e-05	0.000273	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	3.39e-05	0.000272	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	3.38e-05	0.000271	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	3.37e-05	0.00027	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	3.35e-05	0.000269	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	3.3e-05	0.000265	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	3.29e-05	0.000264	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	3.25e-05	0.000261	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	3.24e-05	0.00026	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	3.19e-05	0.000256	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	3.19e-05	0.000256	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	3.15e-05	0.000253	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	3.14e-05	0.000252	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—APOE—multiple sclerosis	3.13e-05	0.000251	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	3.12e-05	0.00025	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	3.1e-05	0.000249	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PGR—multiple sclerosis	3.07e-05	0.000246	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.06e-05	0.000246	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.06e-05	0.000246	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	3.02e-05	0.000242	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	3.01e-05	0.000241	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	3e-05	0.000241	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CD28—multiple sclerosis	2.98e-05	0.000239	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	2.98e-05	0.000239	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	2.95e-05	0.000237	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.94e-05	0.000235	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	2.93e-05	0.000235	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	2.9e-05	0.000233	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CD86—multiple sclerosis	2.88e-05	0.000231	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	2.84e-05	0.000228	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	2.83e-05	0.000227	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CD80—multiple sclerosis	2.83e-05	0.000227	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	2.83e-05	0.000227	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.8e-05	0.000225	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	2.75e-05	0.000221	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	2.75e-05	0.00022	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—APOE—multiple sclerosis	2.75e-05	0.00022	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	2.7e-05	0.000217	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—POMC—multiple sclerosis	2.69e-05	0.000216	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	2.63e-05	0.000211	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	2.62e-05	0.00021	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	2.58e-05	0.000207	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	2.58e-05	0.000207	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	2.55e-05	0.000205	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	2.51e-05	0.000202	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	2.5e-05	0.0002	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	2.5e-05	0.0002	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CD80—multiple sclerosis	2.48e-05	0.000199	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CD86—multiple sclerosis	2.47e-05	0.000198	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	2.44e-05	0.000196	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	2.43e-05	0.000195	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	2.43e-05	0.000195	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	2.39e-05	0.000192	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	2.36e-05	0.000189	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—POMC—multiple sclerosis	2.36e-05	0.000189	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.32e-05	0.000186	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APOE—multiple sclerosis	2.32e-05	0.000186	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	2.31e-05	0.000185	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	2.26e-05	0.000181	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	2.25e-05	0.000181	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	2.22e-05	0.000178	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	2.19e-05	0.000176	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	2.16e-05	0.000173	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	2.14e-05	0.000172	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CD86—multiple sclerosis	2.13e-05	0.000171	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CD80—multiple sclerosis	2.1e-05	0.000168	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	2.1e-05	0.000168	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	2.09e-05	0.000168	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—APOE—multiple sclerosis	2.05e-05	0.000165	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.04e-05	0.000164	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	2.03e-05	0.000163	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—POMC—multiple sclerosis	1.99e-05	0.00016	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.99e-05	0.00016	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2—multiple sclerosis	1.99e-05	0.00016	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	1.98e-05	0.000159	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	1.95e-05	0.000157	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	1.94e-05	0.000156	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.91e-05	0.000153	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	1.89e-05	0.000151	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	1.88e-05	0.000151	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	1.86e-05	0.000149	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	1.85e-05	0.000148	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.8e-05	0.000145	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	1.77e-05	0.000142	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOE—multiple sclerosis	1.77e-05	0.000142	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—POMC—multiple sclerosis	1.76e-05	0.000141	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—multiple sclerosis	1.74e-05	0.00014	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	1.74e-05	0.000139	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.72e-05	0.000138	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.71e-05	0.000137	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.68e-05	0.000134	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	1.67e-05	0.000134	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	1.65e-05	0.000132	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.64e-05	0.000132	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—multiple sclerosis	1.61e-05	0.000129	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—multiple sclerosis	1.56e-05	0.000125	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	1.55e-05	0.000124	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.55e-05	0.000124	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	1.52e-05	0.000122	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.52e-05	0.000122	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—POMC—multiple sclerosis	1.52e-05	0.000122	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.47e-05	0.000118	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—multiple sclerosis	1.47e-05	0.000118	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	1.47e-05	0.000118	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	1.47e-05	0.000118	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.44e-05	0.000116	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.41e-05	0.000113	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	1.4e-05	0.000112	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—multiple sclerosis	1.38e-05	0.000111	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—multiple sclerosis	1.36e-05	0.000109	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	1.36e-05	0.000109	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	1.33e-05	0.000107	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.000107	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.31e-05	0.000105	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.27e-05	0.000102	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.26e-05	0.000101	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	1.24e-05	9.95e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOE—multiple sclerosis	1.23e-05	9.85e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	1.2e-05	9.61e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—multiple sclerosis	1.17e-05	9.38e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—multiple sclerosis	1.15e-05	9.25e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.15e-05	9.23e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.13e-05	9.05e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—multiple sclerosis	1.09e-05	8.75e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	1.08e-05	8.7e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	1.07e-05	8.55e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—POMC—multiple sclerosis	1.05e-05	8.46e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	1.03e-05	8.28e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—multiple sclerosis	1.03e-05	8.23e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—multiple sclerosis	9.9e-06	7.94e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	9.87e-06	7.92e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	9.68e-06	7.77e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—multiple sclerosis	9.61e-06	7.71e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	9.17e-06	7.36e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—multiple sclerosis	8.67e-06	6.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—multiple sclerosis	8.52e-06	6.84e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	8.5e-06	6.82e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	8.34e-06	6.69e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOE—multiple sclerosis	8.02e-06	6.44e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—multiple sclerosis	7.44e-06	5.97e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—POMC—multiple sclerosis	6.89e-06	5.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—multiple sclerosis	6.41e-06	5.14e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—multiple sclerosis	6.28e-06	5.04e-05	CbGpPWpGaD
